NeurAxis, Inc. (NASDAQ:NRXS – Get Free Report)’s share price fell 5.3% on Friday . The stock traded as low as $2.50 and last traded at $2.50. 27,404 shares were traded during mid-day trading, an increase of 138% from the average session volume of 11,518 shares. The stock had previously closed at $2.64.
NeurAxis Stock Down 5.3 %
The firm has a fifty day moving average price of $2.88 and a two-hundred day moving average price of $2.96. The stock has a market capitalization of $17.45 million, a P/E ratio of -1.36 and a beta of 4.15.
NeurAxis Company Profile
NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.
Featured Articles
- Five stocks we like better than NeurAxis
- 3 Warren Buffett Stocks to Buy Now
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Basic Materials Stocks Investing
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Using the MarketBeat Dividend Yield Calculator
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.
